Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after previously ...

Halozyme claims Merck infringed on patents in developing a subcutaneous form of Keytruda. Elsewhere, Vanda’s challenge to an ...

Pfizer Inc. stock hits a 12-year low due to M&A missteps and high debt. Click here to find out why I rate PFE stock a Hold.

Buoyed by the breakthrough technologies and methodologies that have enabled earlier intervention, Alzheimer’s drug developers ...

Overall, Novo is expecting slower growth in 2025. The company is guiding for sales to rise between 16% and 24%, down from 26% ...

Novo Nordisk remains an industry leader, and currently offers both a 2.7% dividend yield and compelling value that can work ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

While Food and Drug Administration inspectors who make sure food and drugs meet quality standards were spared in recent cuts, ...

While JAZZ Pharmaceuticals JAZZ may not be a typical cannabis stock, it is the only company to market an FDA-approved drug ...

Many of the directions included in the order will be familiar to those who watched drug pricing policy closely during the ...

FDA Approves Losartan Oral Suspension Arbli Furoscix (furosemid injection) Loop diuretic Treatment of edema in patients with chronic kidney disease, including nephrotic syndrome. Wearable Furosemide ...

To get FDA approval, scientists must be able to demonstrate that a new drug or treatment is safe and effective. And currently, before they can test a new therapy in humans, they must show proof ...